UBLives is a healthy lifestyle brand focusing on enhancing overall health through innovative technology that alleviates pain, swelling, and fatigue. This Mother’s Day, UBLives is putting health and self-care at
Some of the key Spinal Stenosis Devices companies in the market include- Spinal Simplicity, Boston Scientific Corporation, Medtronic, Stryker, Surgalign, Zimmer Biomet, NuVasive Inc., Sintea Plustek LLC, Orthofix Medical Inc.,
Houston, TX – LIFE Tamil Church Houston gladly announces its launch as a ministry dedicated to supporting Tamil immigrants in the Houston area. This congregation offers worship services in both
Dr. Zenovia Bryant-Bright, acclaimed speaker, strategist, and visionary founder of Bryant Bright Consulting LLC®, is thrilled to announce the launch of her newest podcast, Living Boldly with Dr. Zee! —
As Houston’s business landscape becomes increasingly digital, Mastodon Marketing, a leading full-service digital marketing agency, is empowering local businesses to stand out, connect with customers, and achieve measurable growth. With
A newly published systematic review in Cureus spotlights AI as a critical enabler for protecting sensitive data in healthcare environments. The paper, showcased a Systematic Review and Future Research Perspectives
The Key PCSK9 Inhibitors Companies in the market include – Sirnaomics, Vaxxinity, Verve Therapeutics, Xinlitai Biotechnology, Novo Nordisk, AstraZeneca, Akeso Biopharma, Amgen, Jiangsu Hengrui Medicine Co., Innovent Biologics, LIB Therapeutics,
The Key Polymyalgia Rheumatica Companies in the market include – Roche, Bristol Myers Squibb, Eli-lilly, Novartis, AbbVie, Sparrow Pharmaceuticals, Chugai Pharma, AbbVie, Janssen Research & Development, Sint Maartenskliniek, and others.
The Key Eosinophilic Esophagitis Companies in the market include – Regeneron Pharmaceuticals, Sanofi, Bristol-Myers Squibb, Ellodi Pharmaceuticals, AstraZeneca, Allakos, EsoCap AG, Pfizer, Ception Therapeutics, Celgene, Dr. Falk Pharma GmbH, Revolo
The Key Colorectal Cancer Companies in the market include – Takeda, Genentech/Seagen, AstraZeneca and Daiichi Sankyo, Merck, Amgen, Daiichi Sankyo Company, Mirati Therapeutics, Apollomics, Treos Bio Zrt, AskAt, Effector Therapeutics,
The Key Knee Osteoarthritis Companies in the market include – Taiwan Liposome Company, Centrexion Therapeutics, Biosplice Therapeutic, Noven Pharmaceuticals, Kolon TissueGene, Paradigm Biopharmaceuticals, Organogenesis, BioSenic (Bone Therapeutics), Sorrento Therapeutics, Inc.,
The Key Obesity Companies in the market include – Rhythm Pharmaceuticals, Boehringer Ingelhium, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical, Bukwang Pharmaceutical, Caliway Biopharmaceutics, Yuhan, Terns Pharmaceuticals, BioRestorative Therapies, SCOHIA
The Key Steroid Refactory Acute Graft-Versus-Host Disease Companies in the market include – MaaT Pharma, medac GmbH, AltruBio Inc., Incyte Corporation, and others. The Steroid Refactory Acute Graft-Versus-Host Disease
The Key Myocardial Infarction Companies in the market include – Novartis, AstraZeneca, Recardio, Idorsia Pharmaceuticals, Eli Lilly and Company, Boehringer Ingelheim, Pfizer, Bayer, Mesoblast, Inc., The Medicines Company, Mitsubishi Tanabe
NASH market Report The nonalcoholic steatohepatitis market is poised for significant expansion with the approval of REZDIFFRA and a robust clinical development pipeline. Key companies shaping the future of NASH
ESR1-Mutated Metastatic Breast Cancer Market Report The ESR1-mutated metastatic breast cancer market is witnessing a robust growth trajectory. Key breast cancer companies, including AstraZeneca, Olema Pharmaceuticals, Arvinas, Sermonix Pharmaceuticals, Roche,
Lung Adenocarcinoma Therapeutic Market Report The Lung Adenocarcinoma market is projected to experience robust growth through 2032, driven by advancements in targeted therapies and changing environmental factors. Key lung adenocarcinoma
ER+/HER2- Breast Cancer Market Report The ER+/HER2- breast cancer market is projected to experience significant growth through 2032, driven by rising disease prevalence, advancements in targeted therapies, and an expanding
Nasopharyngeal Carcinoma Treatment Market Nasopharyngeal Carcinoma Companies are Akeso Tiancheng, Inc, Chia Tai Tianqing Pharmaceutical, Hoffmann-La Roche, Novartis, Jiangsu HengRui Medicine, Qilu Pharmaceutical, Akeso, Bristol-Myers Squibb, Sanofi, Innovent Biologics (Suzhou)
Graves’ Disease Treatment Market Graves’ Disease Companies are Apitope International NV, Quintiles Inc., European Commission, Immunovant Sciences GmbH, Novartis Pharmaceuticals, AV7 Limited, Medtronic, Pfizer, Sanguine Biosciences, Tourmaline Bio Inc., Horizon
